US Patent Issued to ELI LILLY and Co. on June 2 for "Dose regimens for use of LY3154207 in the treatment of dopaminergic CNS disorders" (Indiana Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,794, issued on June 2, was assigned to ELI LILLY AND COMPANY (Indianapolis).

"Dose regimens for use of LY3154207 in the treatment of dopaminergic CNS disorders" was invented by Kevin Michael Biglan (Indianapolis), Christina Marie Kiley (Indianapolis) and Kjell Anders Ivan Svensson (Indianapolis).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to dosing regimens and methods of using LY3154207, also described as 2-(2,6-dichlorophenyl)-1-[(1S,3R)-3-(hydroxymethyl)-5-(3-hydroxy-3-methylbutyl)-1-methyl-3,4-dihydroisoquinolin-2 (1H)-yllethanone, and/or pharmaceutical compositions thereof, for treatment of dopaminergic central ne...